Biossil
Toronto, Canada · Founded 2023
- Headquarters
- Toronto
- Employees
- 1–10
- Founded
- 2023
- Business Model
- B2B
- Website
- biossil.co
- Last Round
- SeedFeb 2024
- Rounds
- 2
About
AI-native biopharma drug discovery platform developing targeted therapies for biologically defined patient sub-populations across life-threatening indications.
Summary
Biossil is an Artificial Intelligence company based in Toronto, Canada, founded in 2023. Its most recent funding was a Seed round in Feb 2024. Investors include Golden Ventures.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company